Stock Events

Stock Events

CRISPR Therapeutics (C2RS34.SA) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-9.03

-6.86

-4.7

-2.54

Details

Expected EPS

-7.1053116309

Actual EPS

-9.027646

Surprise EPS

-1.92

Surprise Percent

+27.05%

Description

CRISPR Therapeutics (C2RS34.SA) has reported earnings of -9.027646 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.